Lazard Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $92.06 +2.87%
Rating Summary:
23 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
23 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Lazard Capital initiates coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Buy. PT $57.00.
For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $37.47 yesterday.
For an analyst ratings summary and ratings history on BioMarin Pharmaceutical Inc. click here. For more ratings news on BioMarin Pharmaceutical Inc. click here.
Shares of BioMarin Pharmaceutical Inc. closed at $37.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
- CapitalOne Starts Heron Therapeutics (HRTX) at Overweight
- JPMorgan Starts COSCO SHIPPING Energy Transportation (1138:HK) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
